A Phase Ii Study Of Gemcitabine, Cisplatin, And Bevacizumab For First Recurrent And Refractory Ovarian Clear-Cell Carcinoma (Kcog-G1601 Trial)K. Ito,M. Nakagawa,K. Hori, L. Tashima,M. Goto,S. Yanagida,J. Suzuki,R. Kaya,A. Kawabata,J. Park,H. Nasu,S. Nishio,E. Kondo,M. Kaneda,H. Tsubamoto,A. Arakawa,T. Nagasawa,K. YamadaAnnals of Oncology(2020)引用 1|浏览23暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要